2020
DOI: 10.12701/yujm.2019.00297
|View full text |Cite
|
Sign up to set email alerts
|

Drug-induced liver injury

Abstract: Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Society of Hepatology and European Association for the Study of the Liver guidelines for the diagnosis and treatment of DILI have been established, and they will be helpful for guiding clinical treatment decisions. Roussel Uclaf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 59 publications
0
20
0
2
Order By: Relevance
“…Usually, the drug-induced hepatocyte injury mechanism is divided into three stages: initial hepatocyte injury (cell stress and mitochondrial inhibition), mitochondrial permeability transition, and hepatocyte death (apoptosis and necrosis) ( Russmann et al, 2009 ; Suh, 2020 ). Similarly, in this study, the mechanism of PF-induced hepatotoxicity had also been categorized into the following three stages: ROS accumulation, MMP repression, and hepatocyte apoptosis and steatosis.…”
Section: Discussionmentioning
confidence: 99%
“…Usually, the drug-induced hepatocyte injury mechanism is divided into three stages: initial hepatocyte injury (cell stress and mitochondrial inhibition), mitochondrial permeability transition, and hepatocyte death (apoptosis and necrosis) ( Russmann et al, 2009 ; Suh, 2020 ). Similarly, in this study, the mechanism of PF-induced hepatotoxicity had also been categorized into the following three stages: ROS accumulation, MMP repression, and hepatocyte apoptosis and steatosis.…”
Section: Discussionmentioning
confidence: 99%
“…Animal studies for predicting DILI concerns in the preclinical assessment are not reliable, as it provides a low correlation results in clinical trials and also in post-marketing treatment [ 11 , 12 ]. In vitro and in vivo experiments for detecting DILI of large number of substances are time-consuming and expensive.…”
Section: Introductionmentioning
confidence: 99%
“…Drug-induced liver injury (DILI) is one of the most common etiologies of acute liver failure (ALF) in the United States. Patients may present with a range of clinical manifestations from an asymptomatic transaminase elevation to ALF [1][2][3]. Clinically, DILI has been described as the rise of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than five times the upper limit of normal (ULN), alkaline phosphatase (ALP) greater than two times the ULN, or bilirubin greater than two times the ULN with an associated rise of AST and ALT [4][5].…”
Section: Introductionmentioning
confidence: 99%